129 related articles for article (PubMed ID: 11164689)
1. Effects of alprazolam, caffeine, and zolpidem in humans trained to discriminate triazolam from placebo.
Smith BJ; Bickel WK
Drug Alcohol Depend; 2001 Feb; 61(3):249-60. PubMed ID: 11164689
[TBL] [Abstract][Full Text] [Related]
2. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: II. Comparison with triazolam and caffeine in humans.
Rush CR; Madakasira S; Goldman NH; Woolverton WL; Rowlett JK
J Pharmacol Exp Ther; 1997 Jan; 280(1):174-88. PubMed ID: 8996195
[TBL] [Abstract][Full Text] [Related]
3. Discriminative-stimulus effects of zolpidem, triazolam, pentobarbital, and caffeine in zolpidem-trained humans.
Rush CR; Baker RW; Rowlett JK
Exp Clin Psychopharmacol; 2000 Feb; 8(1):22-36. PubMed ID: 10743902
[TBL] [Abstract][Full Text] [Related]
4. Transduction of the discriminative stimulus effects of zolpidem by GABA(A)/alpha1 receptors.
Rowlett JK; Lelas S; Spealman RD
Eur J Pharmacol; 2000 Oct; 406(1):R9-R10. PubMed ID: 11011051
[TBL] [Abstract][Full Text] [Related]
5. Role of GABAA/benzodiazepine receptors containing alpha 1 and alpha 5 subunits in the discriminative stimulus effects of triazolam in squirrel monkeys.
Lelas S; Rowlett JK; Spealman RD; Cook JM; Ma C; Li X; Yin W
Psychopharmacology (Berl); 2002 May; 161(2):180-8. PubMed ID: 11981598
[TBL] [Abstract][Full Text] [Related]
6. Triazolam discrimination in squirrel monkeys distinguishes high-efficacy agonists from other benzodiazepines and non-benzodiazepine drugs.
Lelas S; Rowlett JK; Spealman RD
Psychopharmacology (Berl); 2001 Feb; 154(1):96-104. PubMed ID: 11292012
[TBL] [Abstract][Full Text] [Related]
7. Zolpidem is differentiated from triazolam in humans using a three-response drug discrimination procedure.
Mintzer MZ; Frey JM; Griffiths RR
Behav Pharmacol; 1998 Nov; 9(7):545-59. PubMed ID: 9862080
[TBL] [Abstract][Full Text] [Related]
8. Differential effects in humans after repeated administrations of zolpidem and triazolam.
Stoops WW; Rush CR
Am J Drug Alcohol Abuse; 2003 May; 29(2):281-99. PubMed ID: 12765207
[TBL] [Abstract][Full Text] [Related]
9. Discriminative stimulus effects of zolpidem in squirrel monkeys: comparison with conventional benzodiazepines and sedative-hypnotics.
Rowlett JK; Spealman RD; Lelas S
J Pharmacol Exp Ther; 1999 Dec; 291(3):1233-41. PubMed ID: 10565847
[TBL] [Abstract][Full Text] [Related]
10. Selective antagonism of the ataxic effects of zolpidem and triazolam by the GABAA/alpha1-preferring antagonist beta-CCt in squirrel monkeys.
Platt DM; Rowlett JK; Spealman RD; Cook J; Ma C
Psychopharmacology (Berl); 2002 Nov; 164(2):151-9. PubMed ID: 12404077
[TBL] [Abstract][Full Text] [Related]
11. Secobarbital in humans discriminating triazolam under two-response and novel-response procedures.
Kamien JB; Bickel WK; Smith BJ; Badger GJ; Hughes JR
Pharmacol Biochem Behav; 1997 Dec; 58(4):983-91. PubMed ID: 9408204
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
[TBL] [Abstract][Full Text] [Related]
13. Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
Greenblatt DJ; Harmatz JS; von Moltke LL; Wright CE; Durol AL; Harrel-Joseph LM; Shader RI
J Pharmacol Exp Ther; 2000 May; 293(2):435-43. PubMed ID: 10773013
[TBL] [Abstract][Full Text] [Related]
14. Discriminative stimulus effects of zolpidem in pentobarbital-trained subjects: I. Comparison with triazolam in rhesus monkeys and rats.
Rowlett JK; Woolverton WL
J Pharmacol Exp Ther; 1997 Jan; 280(1):162-73. PubMed ID: 8996194
[TBL] [Abstract][Full Text] [Related]
15. Flumazenil discrimination by humans under a two-response and a novel-response procedure.
Smith BJ; Bickel WK
J Pharmacol Exp Ther; 1999 Dec; 291(3):1257-68. PubMed ID: 10565850
[TBL] [Abstract][Full Text] [Related]
16. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans.
Oliveto AH; Bickel WK; Hughes JR; Higgins ST; Badger G
Behav Pharmacol; 1997 Jun; 8(2-3):124-38. PubMed ID: 9833008
[TBL] [Abstract][Full Text] [Related]
17. Benzodiazepine-receptor ligands in humans: acute performance-impairing, subject-rated and observer-rated effects.
Rush CR; Armstrong DL; Ali JA; Pazzaglia PJ
J Clin Psychopharmacol; 1998 Apr; 18(2):154-65. PubMed ID: 9555600
[TBL] [Abstract][Full Text] [Related]
18. On the sleep promoting effects of BR-16A: interaction with GABAergic modulators.
Kumar A; Kulkarni SK
Indian J Exp Biol; 2004 May; 42(5):448-51. PubMed ID: 15233467
[TBL] [Abstract][Full Text] [Related]
19. Discriminative-stimulus and participant-rated effects of methylphenidate, bupropion, and triazolam in d-amphetamine-trained humans.
Rush CR; Kollins SH; Pazzaglia PJ
Exp Clin Psychopharmacol; 1998 Feb; 6(1):32-44. PubMed ID: 9526144
[TBL] [Abstract][Full Text] [Related]
20. Differential modulation of the discriminative stimulus effects of methamphetamine and cocaine by alprazolam and oxazepam in male and female rats.
Spence AL; Guerin GF; Goeders NE
Neuropharmacology; 2016 Mar; 102():146-57. PubMed ID: 26541330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
